NEW HOPE, Pa.–(BUSINESS WIRE)–VerdePharmHealth, a medical cannabis group purchasing organization (VerdePharm GPO) coupled with a clinical education & healthcare technology solutions business (VerdePharm Solutions), today announces the appointment of Dave Leverette to the VerdePharmHealth Board of Directors.
Jesse Hollingsworth, Chairman of the Board of Directors, commented: “We are delighted to welcome Dave Leverette to VerdePharmHealth’s Board of Directors. His extensive healthcare expertise and insights will further strengthen the Board and Advisory Panel. Dave’s long and distinguished career, and his significant experience will be invaluable as we continue to progress our comprehensive medical cannabis solutions in the marketplace.”
Board of Director Appointee:
-
Dave Leverette
Mr. Leverette has over 40 years of experience as a senior pharmaceutical executive with significant expertise in commercialization, operations, and product launches. Dave began his career in distinguished sales roles with Durr-Fillauer and Walker Drug until joining the Oncology Supply division of AmerisourceBergen Corporation in 1997. There he served in several senior leadership sales positions until being named President and General Manager of the Oncology Supply division in 2008. Mr. Leverette then transitioned to his appointment as the President of Specialty Physician Services, serving until his retirement in 2018 where he remained a consultant with AmerisourceBergen until this past year.
Commenting on his appointment, Mr. Leverette said: “I’m pleased to be joining the VerdePharmHealth board as the Company embarks on a period of tremendous growth and differentiation in the medical cannabis environment. I look forward to sharing my expertise to help the management team in executing the company’s goal of maximizing value for all stakeholders.”
About VerdePharmHealth
VerdePharmHealth, the first organization of its kind in the U.S., provides comprehensive multi-specialty group purchasing, clinical, and healthcare technology solutions designed to drive high-level commitment and affordability for members. We provide accessibility to the highest quality medical cannabis products from prequalified distributors, in addition to leveraging clinical services and robust technology to improve decisions for interventions at the point of care while monitoring real-world evidence. Utilizing retrospective data and clinical studies for decision-support and standardization of appropriate-use in the care delivery process is a central pillar towards achieving outcomes. For more information, visit www.verdepharmhealth.com or follow VerdePharmHealth on LinkedIn.
Contacts
contact@verdepharmhealth.com or George Raupp, Chief Operating Officer 610.937.1175